Essential Fatty Acids and Eicosanoids in Cutaneous Inflammation

10.1016/S0025-7125(16)31495-X

Greaves MW, 1982, Prostaglandins and dermatology, J R Coll Physicians Lond., 16, 219

Horrobin DF, 1983, The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism, Rev Pure Appl Pharmacol Sci., 4, 339

10.1172/JCI111312

10.1126/science.6301011

Kragballe K, 1983, Arachidonic acid and leukotrienes in dermatology, J Invest Dermatol., 8, 293

Voorhees JJ, 1983, Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses, Arch Dermatol., 119, 541, 10.1001/archderm.1983.01650310003001

10.1038/293103a0

10.1016/0006-291X(80)91548-X

10.1016/0006-291X(85)90989-1

10.1056/NEJM198505093121901

10.1056/NEJM198505093121909

10.1056/NEJM198010023031421

10.1016/S0190-9622(84)80274-1

10.1073/pnas.76.11.5919

10.1136/bmj.288.6417.592

10.1146/annurev.bi.47.070178.005025

Friedman Z., 1980, Essential fatty acids revisited, Am J Dis Child., 134, 397

10.1177/000348946707600517

10.1177/000348946907800320

10.1016/S0140-6736(82)91365-4

10.1016/0090-6980(82)90124-1

10.1016/0091-6749(84)90144-1

10.1073/pnas.78.6.3887

10.1111/1523-1747.ep12525265

Goldyne ME, 1986, Lymphocyte and monocyte/macrophage interactions involving arachidonic acid metabolism, Transplant Proc., 18, 37

Brain SD, 1982, The synthesis of leukotriene B4‐like material by cultured human keratinocytes, J Invest Dermatol., 78, 328

10.1016/0006-291X(77)91253-0

10.1016/0006-2952(84)90096-0

10.1111/1523-1747.ep12277329

10.1016/S0190-9622(87)70098-X

10.1111/1523-1747.ep12525241

10.1136/bmj.3.5881.608

Barr RM, 1983, Lipoxygenase products of arachidonic acid in inflamed skin, J Invest Dermatol., 80, 345

Camp RDR, 1982, Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4, J Invest Dermatol., 78, 329

Barr R, 1982, Raised arachdonic acid and prostaglandin levels in dithranol erythema: time course study, J Invest Dermatol., 78, 328

10.1111/1523-1747.ep12531738

10.1111/1523-1747.ep12525225

Sondergaard J, 1985, Eicosanoids in skin UV inflammation, Photodermatology., 2, 359

Marks F, 1981, Prostaglandin E‐mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12–0‐tetradecanoylphorbol‐13‐acetate, Cancer Res., 41, 696

10.1111/1523-1747.ep12264114

10.1111/j.1365-2125.1978.tb04595.x

10.1111/1523-1747.ep12676722

10.1111/1523-1747.ep12492445

10.1056/NEJM198505093121903

10.1073/pnas.76.2.944

10.1073/pnas.80.12.3581

10.1016/0006-291X(83)91235-4

10.1172/JCI111612

10.1172/JCI110288

Hammarstrom S., 1980, Leukotriene C5: a slow reacting substance derived from eicosapentaenoic acid, J Biol Chem., 255, 7093, 10.1016/S0021-9258(20)79667-5

10.1016/S0021-9258(17)43363-1

10.1016/S0021-9258(17)42835-3

10.1016/0090-6980(84)90075-3

10.1016/S0140-6736(78)91505-2

10.1016/S0140-6736(80)90995-2

10.1016/S0140-6736(79)91490-9

10.1056/NEJM198505093121902

Russo‐Marie F, 1979, Involvement of glucocorticoid receptors in steroid‐induced inhibition of prostaglandin secretion, J Biol Chem., 254, 8498, 10.1016/S0021-9258(19)86919-3

10.1038/287147a0

Stone J, 1985, Dermatologic Immunology and Allergy, 649

Rola‐Plexzcynski M., 1985, Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions, J Immunol., 135, 1357, 10.4049/jimmunol.135.2.1357

Colditz IC, 1984, Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxis and che‐motaxinigens, J Immunol., 133, 2169, 10.4049/jimmunol.133.4.2169

10.1016/0008-8749(70)90003-1

10.1111/j.1365-2133.1978.tb15211.x

Esterly NB, 1984, Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy, Arch Dermatol., 120, 1308, 10.1001/archderm.1984.01650460048018

10.1093/infdis/129.2.110

10.1111/1523-1747.ep12543487

10.1111/1523-1747.ep12259225

10.1056/NEJM196510142731604

10.1038/jid.1961.66

10.1111/1523-1747.ep12491639

10.1007/BF00403729

10.1111/1523-1747.ep12514573

10.1016/S0140-6736(82)92532-6

10.1111/j.2042-7158.1979.tb13657.x

10.1016/S0140-6736(84)92293-1

10.1016/0006-2952(84)90220-X

10.1016/0090-6980(85)90097-8

10.1016/S0140-6736(84)90840-7

10.1016/S0140-6736(84)91536-8

Benoxaprofen (Oraflex) and piroxicam (Feldene), 1982, Two new drugs for arthritis, Med Lett Drugs Ther., 24, 63

Hamdy RC, 1982, The pharmacokinetics of benoxaprofen in elderly subjects, Eur J Rheumatol Inflamm., 5, 69

Bokoch GM, 1981, Evidence for inhibition of leukotriene A4 synthesis by 5,8,11,13‐eicosatetraynoic acid in guinea pig polymorphonuclear keukocytes, J Biol Chem., 256, 4156, 10.1016/S0021-9258(19)69410-X

10.1038/jid.1967.78

10.1016/S0190-9622(85)80375-3

10.1016/S0190-9622(84)80192-9

10.1016/S0190-9622(86)70025-X

10.1111/j.1753-4887.1981.tb06740.x

10.1001/archderm.1959.01560180018005

Brain S, 1983, Biological activity due to arachidonic acid lipoxygenase products in psoriasis, J Invest Dermatol., 80, 360

10.1111/1523-1747.ep12581645

10.1016/0091-6749(84)90142-8

Jablonska S, 1982, Stripping of the stratum corneum in patients with psoriasis, Arch Dermatol., 18, 652, 10.1001/archderm.1982.01650210032013

10.1016/0262-1746(84)90201-4

10.1016/S0140-6736(82)90939-4

10.1073/pnas.72.12.5130

10.1111/j.1365-2133.1983.tb04585.x

10.1126/science.887938

10.1111/1523-1747.ep12273519

Camp RDR, 1982, Responses of human skin to intradermal injection of leukotrienes C4, D4, and B4, Br J Pharmacol., 75, 168P

10.1111/1523-1747.ep12259945

10.1111/1523-1747.ep12276933

Goetzl EJ, 1980, Modulation of human neutrophil function by monohydroxyeicosatetraenoic acids, Immunology., 39, 491

Kragballe K., 1984, Leukotrienes and potent stimulators of DNA synthesis of human keratinocyte cultures, J Invest Dermatol., 82, 398

10.1172/JCI112283

10.1016/S0140-6736(82)91365-4

10.1007/BF00417210

10.1111/1523-1747.ep12284061

10.1111/j.1365-2133.1986.tb02779.x

10.1111/1523-1747.ep12523561

10.1136/bmj.285.6350.1241

10.1001/archderm.119.7.548

Ellis CN, 1983, Topical indomethacin exacerbates lesions of psoriasis, J Invest Dermatol., 80, 362

10.1111/j.1346-8138.1981.tb02551.x

10.1073/pnas.82.21.7227

10.1073/pnas.77.1.308

10.1073/pnas.75.6.2955

10.1038/287171a0

10.1016/0006-291X(83)91714-X

Benford CJ, 1983, Effects of anti‐psoriatic drugs on cyclo‐oxygenase and lipoxygenase activities of mouse epidermis and human bolld platelets, Clin Res., 31, 556A

10.1111/1523-1747.ep12523249

10.1016/S0190-9622(86)70004-2

10.1001/archderm.1986.01660230069013

10.1056/NEJM198508013130502

10.1016/S0091-6749(84)80008-1

Hanifin JM, 1980, Diagnostic features of atopic dermatitis, Acta Derm Venereol (Stockh)., 92, 44, 10.2340/00015555924447

10.1016/S0190-9622(82)70001-5

10.1016/S0190-9622(83)80228-X

10.1016/S0140-6736(84)92142-1

10.1016/S0140-6736(84)91071-7

10.1111/1523-1747.ep12284061

10.1111/j.1365-4362.1985.tb05759.x

Hammarstrom JL, 1982, Effects of intradermally injected leukotriene Cy and histamine in patients with urticaria, psoriasis, and atopic dermatitis, Br J Dermatol., 107, 106, 10.1111/j.1365-2133.1982.tb01041.x

10.1093/ajcn/34.2.252

10.1016/0262-1746(82)90050-6

10.1016/S0140-6736(82)92784-2

10.1016/S0190-9622(85)70245-9

10.1016/0262-1746(82)90019-1

10.1111/j.1365-2133.1984.tb04698.x

10.1016/0005-2760(68)90126-4

10.1172/JCI109752

10.1016/0090-6980(82)90031-4

Kinsella JE, 1981, Metabolism of trans fatty acids with emphasis on the effects of trans, transactadeca‐dienoate on lipid composition, essential fatty acid, and prostaglandins an overview, Am J Clin Nutr., 34, 2307, 10.1093/ajcn/34.10.2307

Ziboh VA, 1983, Biosynthesis of prostaglandin E2 in human skin: subcellular localization and inhibition by unsaturated fatty acids and anti‐inflammatory drugs, J Lipid Res., 14, 379